Targeted Cationic Liposomes, Technologies, and Developments

The author provides a brief review of tumor-specific and liver-targeted cationic liposomes and the strategies for the development of liposome-ligand complexes.

Related Content:

Drug DeliveryDevelopmentPharmaceutical Technology-12-02-2003

With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs

Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia

Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC